Financial Data and Key Metrics Changes - The company reported revenues of 1.22 [17] - The adjusted compensation expense ratio remained stable at 61.5% for both fiscal 2025 and 2024 [26] - Adjusted other income and expense produced income of approximately 3 million in the same period last year, primarily due to a net increase in interest income [27] - The adjusted effective tax rate for the quarter was 31.2%, compared to 29.2% for the same quarter last year, driven by increased non-deductible expenses [44] Business Line Data and Key Metrics Changes - Corporate Finance generated 117 million, a 5% decrease from the previous year, with 33 transactions closed, up from 30 [21] - Financial and Valuation Advisory (FVA) produced 485 million in unrestricted cash and equivalents, with a decline in cash position due to bonus payments [28] Q&A Session Summary Question: What is the outlook for Corporate Finance? - Management noted continued improvement in Corporate Finance, with a focus on transaction size and close rates, benefiting from a stronger reputation in Europe [48][49] Question: How is the restructuring business performing? - Management indicated that the restructuring business can be lumpy, but they do not see recent restructuring events as a sign of broader market issues [32] Question: What are the growth opportunities in private funds? - Management highlighted the evolving nature of the private funds market, particularly in secondaries and directs, as areas of growth potential [36] Question: How is the company positioned for capital markets activity? - Management stated that the capital markets business is growing due to increased private capital market activity and is well-positioned for future opportunities [55] Question: What is the trajectory for restructuring in the coming years? - Management expects the distressed business to continue growing, with a stable percentage of defaults anticipated [64] Question: What is the outlook for non-compensation expenses? - Management expects non-compensation expenses to normalize, with a trajectory dependent on revenue growth [97]
Houlihan Lokey(HLI) - 2025 Q1 - Earnings Call Transcript